Vanguard Group Inc Liquidia Corp Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Liquidia Corp stock. As of the latest transaction made, Vanguard Group Inc holds 3,441,929 shares of LQDA stock, worth $49.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,441,929
Previous 3,401,753
1.18%
Holding current value
$49.3 Million
Previous $40.8 Million
15.68%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding LQDA
# of Institutions
169Shares Held
44.3MCall Options Held
1.55MPut Options Held
1.52M-
Patient Square Capital LP Menlo Park, CA7.18MShares$103 Million26.66% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$60.8 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$47.2 Million0.17% of portfolio
-
Findell Capital Management LLC New York, NY3.19MShares$45.8 Million16.08% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.27MShares$32.5 Million1.86% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $922M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...